Adult Pure Erythroid Leukemia — Trials

Adult Pure Erythroid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

68 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (20)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00093470	Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission	completed	Phase 3	144	National Cancer Institute (NCI)NIH	3	Jul 14, 2026	clinicaltrials
NCT02085408	Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia	completed	Phase 3	727	ECOG-ACRIN Cancer Research GroupNETWORK	3	Dec 13, 2024